Theriva Biologics Inc (TOVX)
0.4195
+0.01
(+2.33%)
USD |
NYAM |
Apr 26, 16:00
0.4199
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Cash from Operations (TTM): -19.00M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -19.00M |
September 30, 2023 | -17.82M |
June 30, 2023 | -19.33M |
March 31, 2023 | -19.79M |
December 31, 2022 | -19.08M |
September 30, 2022 | -18.52M |
June 30, 2022 | -16.22M |
March 31, 2022 | -14.46M |
December 31, 2021 | -12.89M |
September 30, 2021 | -11.21M |
June 30, 2021 | -11.11M |
March 31, 2021 | -10.54M |
December 31, 2020 | -12.17M |
September 30, 2020 | -12.64M |
June 30, 2020 | -13.65M |
March 31, 2020 | -14.61M |
December 31, 2019 | -13.87M |
September 30, 2019 | -13.56M |
June 30, 2019 | -14.10M |
March 31, 2019 | -15.42M |
December 31, 2018 | -17.28M |
September 30, 2018 | -17.92M |
June 30, 2018 | -18.84M |
March 31, 2018 | -20.28M |
December 31, 2017 | -20.20M |
Date | Value |
---|---|
September 30, 2017 | -26.66M |
June 30, 2017 | -28.12M |
March 31, 2017 | -28.24M |
December 31, 2016 | -27.90M |
September 30, 2016 | -28.49M |
June 30, 2016 | -37.72M |
March 31, 2016 | -39.11M |
December 31, 2015 | -38.89M |
September 30, 2015 | -32.70M |
June 30, 2015 | -22.02M |
March 31, 2015 | -18.07M |
December 31, 2014 | -16.08M |
September 30, 2014 | -14.00M |
June 30, 2014 | -11.19M |
March 31, 2014 | -9.527M |
December 31, 2013 | -7.719M |
September 30, 2013 | -9.788M |
June 30, 2013 | -9.51M |
March 31, 2013 | -9.163M |
December 31, 2012 | -8.916M |
September 30, 2012 | -4.874M |
June 30, 2012 | -4.343M |
March 31, 2012 | -4.009M |
December 31, 2011 | -2.875M |
September 30, 2011 | -2.809M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-19.79M
Minimum
Mar 2023
-10.54M
Maximum
Mar 2021
-14.98M
Average
-14.10M
Median
Jun 2019
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Oragenics Inc | -7.291M |
Nanoviricides Inc | -6.127M |